Patents by Inventor Mingyong Liang

Mingyong Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250115584
    Abstract: The present invention belongs to the field of pharmaceutical and chemical engineering, and relates to a high-purity losartan potassium and a preparation method therefor. The present invention also relates to a high-purity losartan or a pharmaceutically acceptable salt thereof and a preparation method therefor. The present invention uses organic phosphorus to reduce an azide compound to an amino compound so that the genotoxicity of losartan or a pharmaceutically acceptable salt thereof can be well controlled. The method of the present invention involves fewer steps, uses a small amount of reagent, does not require activated carbon decolorization, and produces a high-purity product, and therefore is suitable for industrial production and is very practical.
    Type: Application
    Filed: December 14, 2022
    Publication date: April 10, 2025
    Inventors: Shengjun Li, Yang Zheng, Aixing Li, Cuiting Liang, Mingyong Bai, Zhantao Zhang, Zunjun Liang, Fengfeng Yan
  • Patent number: D970451
    Type: Grant
    Filed: March 9, 2022
    Date of Patent: November 22, 2022
    Assignee: Zhejiang Desuoer Health Technology Co., Ltd.
    Inventor: Mingyong Liang
  • Patent number: D978084
    Type: Grant
    Filed: March 9, 2022
    Date of Patent: February 14, 2023
    Assignee: Zhejiang Desuoer Health Technology Co., Ltd.
    Inventor: Mingyong Liang
  • Patent number: D1027322
    Type: Grant
    Filed: January 24, 2024
    Date of Patent: May 14, 2024
    Assignee: Zhejiang Desuoer Health Technology Co., Ltd.
    Inventor: Mingyong Liang